MARVELD1 as a tumor stem cell marker and therapeutic target in visceral obesity-associated ovarian cancer

A VORG-based prognostic model was established that correlates with OC prognosis, tumor immune microenvironment, and treatment sensitivity. These findings suggest that MARVELD1 and related pathways may serve as potential targets to improve prognostic stratification and guide therapy in OC.

Authors

Xianping Zhou

Institutions

Bozhou People's Hospital (CN)

Publication Details

Journal: American Journal of Cancer Research
Published: 2025-01-01
DOI: https://doi.org/10.62347/mbkk6687
Primary Topic: Ferroptosis and cancer prognosis
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

MARVELD1 as a tumor stem cell marker and therapeutic target in visceral obesity-associated ovarian cancer

Xianping Zhou

Jan 1, 2025

American Journal of Cancer Research

Ferroptosis and cancer prognosis

article

MARVELD1 as a tumor stem cell marker and therapeutic target in visceral obesity-associated ovarian cancer

Xianping Zhou

January 1, 2025article en

Abstract

American Journal of Cancer ResearchVol. 15(11)

Bozhou People's Hospital (CN)

Openalex Percentile: Top 41%

Ferroptosis and cancer prognosis

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MARVELD1 as a tumor stem cell marker and therapeutic target in visceral obesity-associated ovarian cancer — Xianping Zhou · American Journal of Cancer Research (2025) | TGRS Research Map | TGRS